Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
sennes 12,4 % + loppefrø 54,2 % granulat |
Is a |
Product containing senna (medicinal product) |
false |
Inferred relationship |
Some |
|
|
sennes 12,4 % + loppefrø 54,2 % granulat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Senna (substance) |
false |
Inferred relationship |
Some |
|
|
sennes 12,4 % + loppefrø 54,2 % granulat |
Is a |
Product containing psyllium and senna (medicinal product) |
false |
Inferred relationship |
Some |
|
|
sennes 12,4 % + loppefrø 54,2 % granulat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ispaghula husk (substance) |
false |
Inferred relationship |
Some |
|
|
sennes 12,4 % + loppefrø 54,2 % granulat |
Has manufactured dose form |
A solid dose form consisting of dry aggregates of powder particles that are sufficiently resistant to withstand handling. |
false |
Inferred relationship |
Some |
|
|
sennes 12,4 % + loppefrø 54,2 % granulat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antilipemic agent (substance) |
false |
Inferred relationship |
Some |
|
|
sennes 12,4 % + loppefrø 54,2 % granulat |
Has manufactured dose form |
Oral granules |
false |
Inferred relationship |
Some |
|
|
sennes 12,4 % + loppefrø 54,2 % granulat |
Is a |
Product manufactured as oral dose form (product) |
false |
Inferred relationship |
Some |
|
|
sennes 12,4 % + loppefrø 54,2 % granulat |
Is a |
Senna-containing product in oral dose form |
false |
Inferred relationship |
Some |
|
|
sennes 12,4 % + loppefrø 54,2 % granulat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Psyllium (substance) |
false |
Inferred relationship |
Some |
|
|
sennes 12,4 % + loppefrø 54,2 % granulat |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Some |
|
|